You are here

drug launches

bluebird bio Prepares for Launch

bluebird bio Prepares for Launch

Motley Fool

beta-thalassemia

Flag link:

FDA-approved Humira copycat from Merck, Samsung Bioepis will wait 4 years to launch

FDA-approved Humira copycat from Merck, Samsung Bioepis will wait 4 years to launch

Endpoints

Samsung Bioepis

Flag link:

Pfizer's keys to juggling 8 U.S. launches? Organization, accountability, clear goals

Pfizer's keys to juggling 8 U.S. launches? Organization, accountability, clear goals

Fierce Pharma

Flag link:

Novartis amps up Symjepi launch to fill Pfizer's EpiPen supply gap

Novartis amps up Symjepi launch to fill Pfizer's EpiPen supply gap

Fierce Pharma

Adamis Pharmaceuticals

Flag link:

First Generic Launch has Significant First-Mover Advantage Over Later Generic Drug Entrants

First Generic Launch has Significant First-Mover Advantage Over Later Generic Drug Entrants

Drug Patent Watch

Flag link:

Catalyst Pharma Focuses on Firdapse Launch & Label Expansion

Catalyst Pharma Focuses on Firdapse Launch & Label Expansion

Yahoo/Zacks.com

Catalyst Pharma

Flag link:

Eyeing a drug launch in early ’20, Esperion lines up a new, $200M funding deal

Eyeing a drug launch in early ’20, Esperion lines up a new, $200M funding deal

Endpoints

Esperion Therapeutics

Flag link:

AbbVie's discounting Humira to aid Skyrizi's launch—and a price war could follow: analyst

AbbVie's discounting Humira to aid Skyrizi's launch—and a price war could follow: analyst

Fierce Pharma

Flag link:

Evolus sparks controversy with Cancun beach bash ahead of Jeuveau launch

Evolus sparks controversy with Cancun beach bash ahead of Jeuveau launch

Fierce Pharma

Flag link:

Getting Clinical On New Drug Launches

Getting Clinical On New Drug Launches

Forbes

clinical trials

Flag link:

Puma Biotech’s new cancer drug Nerlynx suffered a terrible quarter. What gives?

Puma Biotech’s new cancer drug Nerlynx suffered a terrible quarter. What gives?

Fierce Pharma

Puma Biotechnology

Flag link:

Bluebird's not looking to break speed records with its first gene therapy launch

Bluebird's not looking to break speed records with its first gene therapy launch

Fierce Pharma

beta thalassemia

Flag link:

With potential launches nearing, Zai taps investors for $200M

With potential launches nearing, Zai taps investors for $200M

BioCentury

Flag link:

Alexion gets off to the races with key Ultomiris, Soliris launches

Alexion gets off to the races with key Ultomiris, Soliris launches

Fierce Pharma

Flag link:

4 Blockbuster Drug Launches to Watch in 2019

4 Blockbuster Drug Launches to Watch in 2019

Motley Fool

Alexion Pharmaceuticals

Aimmune Therapeutics

rheumatoid arthritis

Flag link:

Successful launch bolsters Libtayo's place as cornerstone therapy for Regeneron

Successful launch bolsters Libtayo's place as cornerstone therapy for Regeneron

Biopharma Dive

Flag link:

AstraZeneca kicks off second blood cancer launch, this time for orphan drug Lumoxiti

AstraZeneca kicks off second blood cancer launch, this time for orphan drug Lumoxiti

Fierce Pharma

hairy cell leukemia

Flag link:

Lessons From The Biggest Pharma Drug Launches Of All Time

Lessons From The Biggest Pharma Drug Launches Of All Time

Forbes

Gilead Sciences

Flag link:

Ferring launches Nocdurna in US to treat nocturia due to NP

Ferring launches Nocdurna in US to treat nocturia due to NP

Pharmaceutical Business Review

nocturnal polyuria

Flag link:

As Novartis' other cancer launches struggle, Lutathera gets off to flying start

As Novartis' other cancer launches struggle, Lutathera gets off to flying start

Fierce Pharma

neuroendocrine tumors

Flag link:

Pages